ASPEN AEROGELS INC (ASPN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:ASPN - US04523Y1055 - Common Stock
3.54 USD
-0.09 (-2.48%)
3.61 USD
+0.07 (+1.98%)
Taking everything into account, ASPN scores 3 out of 10 in our fundamental rating. ASPN was compared to 81 industry peers in the Chemicals industry. The financial health of ASPN is average, but there are quite some concerns on its profitability. ASPN is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year ASPN has reported negative net income.
In the past year ASPN had a positive cash flow from operations.
In the past 5 years ASPN reported 4 times negative net income.
In the past 5 years ASPN reported 4 times negative operating cash flow.
1.2 Ratios
ASPN has a worse Return On Assets (-62.12%) than 93.83% of its industry peers.
With a Return On Equity value of -99.85%, ASPN is not doing good in the industry: 86.42% of the companies in the same industry are doing better.
ASPN's Return On Invested Capital of 2.43% is on the low side compared to the rest of the industry. ASPN is outperformed by 64.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -62.12% | ||
| ROE | -99.85% | ||
| ROIC | 2.43% |
ROA(3y)-5.96%
ROA(5y)-12.11%
ROE(3y)-8.57%
ROE(5y)-17.34%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ASPN has a worse Operating Margin (3.27%) than 69.14% of its industry peers.
ASPN has a better Gross Margin (32.89%) than 65.43% of its industry peers.
ASPN's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.27% | ||
| PM (TTM) | N/A | ||
| GM | 32.89% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y70.57%
GM growth 5Y16.45%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ASPN is destroying value.
The number of shares outstanding for ASPN has been increased compared to 1 year ago.
Compared to 5 years ago, ASPN has more shares outstanding
ASPN has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -0.51, we must say that ASPN is in the distress zone and has some risk of bankruptcy.
ASPN has a worse Altman-Z score (-0.51) than 83.95% of its industry peers.
The Debt to FCF ratio of ASPN is 46.99, which is on the high side as it means it would take ASPN, 46.99 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 46.99, ASPN is in line with its industry, outperforming 44.44% of the companies in the same industry.
A Debt/Equity ratio of 0.31 indicates that ASPN is not too dependend on debt financing.
ASPN has a Debt to Equity ratio of 0.31. This is in the better half of the industry: ASPN outperforms 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 46.99 | ||
| Altman-Z | -0.51 |
ROIC/WACC0.28
WACC8.62%
2.3 Liquidity
A Current Ratio of 3.94 indicates that ASPN has no problem at all paying its short term obligations.
The Current ratio of ASPN (3.94) is better than 90.12% of its industry peers.
A Quick Ratio of 3.33 indicates that ASPN has no problem at all paying its short term obligations.
ASPN's Quick ratio of 3.33 is amongst the best of the industry. ASPN outperforms 93.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.94 | ||
| Quick Ratio | 3.33 |
3. Growth
3.1 Past
ASPN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -129.73%.
The Revenue for ASPN has decreased by -14.74% in the past year. This is quite bad
The Revenue has been growing by 26.56% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-129.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.11%
Revenue 1Y (TTM)-14.74%
Revenue growth 3Y54.99%
Revenue growth 5Y26.56%
Sales Q2Q%-37.77%
3.2 Future
ASPN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.38% yearly.
The Revenue is expected to grow by 4.06% on average over the next years.
EPS Next Y-846.37%
EPS Next 2Y-72.49%
EPS Next 3Y3.33%
EPS Next 5Y41.38%
Revenue Next Year-32.59%
Revenue Next 2Y-14.45%
Revenue Next 3Y0.58%
Revenue Next 5Y4.06%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ASPN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 89.98 indicates a quite expensive valuation of ASPN.
Based on the Price/Forward Earnings ratio, ASPN is valued a bit more expensive than the industry average as 69.14% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 36.10. ASPN is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 89.98 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ASPN is valued a bit cheaper than the industry average as 69.14% of the companies are valued more expensively.
The rest of the industry has a similar Price/Free Cash Flow ratio as ASPN.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 108.97 | ||
| EV/EBITDA | 8.11 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-72.49%
EPS Next 3Y3.33%
5. Dividend
5.1 Amount
No dividends for ASPN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
3.54
-0.09 (-2.48%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners73.41%
Inst Owner Change0.61%
Ins Owners1.14%
Ins Owner Change-0.15%
Market Cap292.58M
Revenue(TTM)352.85M
Net Income(TTM)-305.28M
Analysts75.71
Price Target7.82 (120.9%)
Short Float %13.97%
Short Ratio3.8
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-101.12%
Min EPS beat(2)-176.85%
Max EPS beat(2)-25.4%
EPS beat(4)2
Avg EPS beat(4)-32.06%
Min EPS beat(4)-176.85%
Max EPS beat(4)57.28%
EPS beat(8)6
Avg EPS beat(8)89.76%
EPS beat(12)10
Avg EPS beat(12)72.04%
EPS beat(16)10
Avg EPS beat(16)45.6%
Revenue beat(2)1
Avg Revenue beat(2)2.56%
Min Revenue beat(2)-0.36%
Max Revenue beat(2)5.47%
Revenue beat(4)1
Avg Revenue beat(4)-0.43%
Min Revenue beat(4)-6.73%
Max Revenue beat(4)5.47%
Revenue beat(8)5
Avg Revenue beat(8)5.37%
Revenue beat(12)7
Avg Revenue beat(12)4.61%
Revenue beat(16)9
Avg Revenue beat(16)3.03%
PT rev (1m)-20%
PT rev (3m)-14.02%
EPS NQ rev (1m)-1619.54%
EPS NQ rev (3m)-1619.54%
EPS NY rev (1m)0%
EPS NY rev (3m)0.04%
Revenue NQ rev (1m)-33.34%
Revenue NQ rev (3m)-33.34%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 89.98 | ||
| P/S | 0.83 | ||
| P/FCF | 108.97 | ||
| P/OCF | 5.58 | ||
| P/B | 0.96 | ||
| P/tB | 0.96 | ||
| EV/EBITDA | 8.11 |
EPS(TTM)-0.11
EYN/A
EPS(NY)0.04
Fwd EY1.11%
FCF(TTM)0.03
FCFY0.92%
OCF(TTM)0.63
OCFY17.92%
SpS4.27
BVpS3.7
TBVpS3.7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -62.12% | ||
| ROE | -99.85% | ||
| ROCE | 2.74% | ||
| ROIC | 2.43% | ||
| ROICexc | 3.79% | ||
| ROICexgc | 3.79% | ||
| OM | 3.27% | ||
| PM (TTM) | N/A | ||
| GM | 32.89% | ||
| FCFM | 0.76% |
ROA(3y)-5.96%
ROA(5y)-12.11%
ROE(3y)-8.57%
ROE(5y)-17.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y70.57%
GM growth 5Y16.45%
F-Score4
Asset Turnover0.72
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 46.99 | ||
| Debt/EBITDA | 2.77 | ||
| Cap/Depr | 221.9% | ||
| Cap/Sales | 14.1% | ||
| Interest Coverage | 0.81 | ||
| Cash Conversion | 154.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.94 | ||
| Quick Ratio | 3.33 | ||
| Altman-Z | -0.51 |
F-Score4
WACC8.62%
ROIC/WACC0.28
Cap/Depr(3y)1152.87%
Cap/Depr(5y)727.63%
Cap/Sales(3y)63.74%
Cap/Sales(5y)41.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-129.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.11%
EPS Next Y-846.37%
EPS Next 2Y-72.49%
EPS Next 3Y3.33%
EPS Next 5Y41.38%
Revenue 1Y (TTM)-14.74%
Revenue growth 3Y54.99%
Revenue growth 5Y26.56%
Sales Q2Q%-37.77%
Revenue Next Year-32.59%
Revenue Next 2Y-14.45%
Revenue Next 3Y0.58%
Revenue Next 5Y4.06%
EBIT growth 1Y-73.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-34.26%
EBIT Next 3Y26.7%
EBIT Next 5Y25.05%
FCF growth 1Y100.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y182.02%
OCF growth 3YN/A
OCF growth 5YN/A
ASPEN AEROGELS INC / ASPN FAQ
Can you provide the ChartMill fundamental rating for ASPEN AEROGELS INC?
ChartMill assigns a fundamental rating of 3 / 10 to ASPN.
What is the valuation status for ASPN stock?
ChartMill assigns a valuation rating of 1 / 10 to ASPEN AEROGELS INC (ASPN). This can be considered as Overvalued.
How profitable is ASPEN AEROGELS INC (ASPN) stock?
ASPEN AEROGELS INC (ASPN) has a profitability rating of 1 / 10.
Can you provide the expected EPS growth for ASPN stock?
The Earnings per Share (EPS) of ASPEN AEROGELS INC (ASPN) is expected to decline by -846.37% in the next year.